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1116 | Chem. Sci., 2017, 8, 1116–1126vity of an isolated enoyl reductase
catalytic domain from an iterative highly reducing
fungal polyketide synthase reveals key components
of programming†
Douglas M. Roberts,ab Christoph Bartel,b Alan Scott,a David Ivison,a
Thomas J. Simpsona and Russell J. Cox*ab
A cis-acting enoyl reductase (ER) catalytic domain was isolated from a fungal highly reducing iterative
polyketide synthase (HR-iPKS) for the ﬁrst time and studied in vitro. The ER from the squalestatin
tetraketide synthase forms a discrete dimeric protein in solution. The ER shows broad substrate
selectivity, reducing enoyl species including both natural and unnatural substrates. Pantetheine-bound
substrate thiolesters reacted much faster than the corresponding SNAC thiolesters. The unnatural
substrates included Z-oleﬁns, 2-ethyl oleﬁns and pentaketides. Methylation of the substrate modiﬁes the
activity of the ER such that the 2,4-dimethyl oct-2-enoyl substrate ﬁts into the active site but cannot be
reduced. A new NMR-based assay was developed for the direct observation of the stereochemical
preferences at the 40 position of the NADPH cofactor and the C-2 and C-3 positions of the substrates.
The assay reveals that the fungal iPKS ER-catalysed reaction is stereochemically identical to that of the
vertebrate FAS (vFAS) at the cofactor 40 position and the substrate 3-position, but the high
stereoselectivity displayed by intact SQTKS is lost such that reprotonation at the 2-position is unselective
by the isolated ER. A 3D model of ER was consistent with these observations and showed that the ER
may sequester its ﬁnal substrate to prevent further chain extension. The results support a developing
model for programming by HR-iPKS in which competition for substrates between restrictive and
permissive catalytic domains chaperones the growing polyketide to completion, while allowing for errors
and evolution.Fungal polyketides are highly diverse secondary metabolites
which are created by iterative type I polyketide synthases
(iPKS).1,2 These enzymes diﬀer from the better-understood
modular polyketide synthases (mPKS) present in bacteria in
which each synthesis module is usually responsible for a single
chain extension and modication cycle. The synthetic pro-
gramme of mPKS arises as a result of the number of modules
(which controls the chain-length) and the presence or absence
of modifying domains in each individual module (which dictate
the chemical functionality at each backbone carbon).3 The
consequence is that the chemical products of modular PKS can
oen be predicted from the PKS peptide sequence. In contrast,
fungal PKS consist of single modules which are iterative. Since
neither the number of cycles of chain extension nor the oper-
ation of each individual modifying domain in each successiveantock's Close, Bristol BS8 1TS, UK
bniz Universita¨t Hannover, Schneiderberg
sell.cox@oci.uni-hannover.de
n (ESI) available: Details of all
ee DOI: 10.1039/c6sc03496acycle can be predicted, the programmes of fungal PKS (and
indeed the programming mechanisms themselves) remain
cryptic.
The fungal highly-reducing (HR) class of iPKS consist of
b-ketoacyl ACP synthase (KS), acyl transferase (AT), dehydratase
(DH), C-methyl transferase (C-MeT), enoyl reductase (ER), keto-
reductase (KR) and acyl carrier protein (ACP) catalytic domains.
They are thus very similar in domain-order to single modules of
mPKS and also the iterative vertebrate fatty acid synthases
(vFAS)4 – to which they also show signicant sequence homology.
However, vFAS enzymes display almost no programming as all
domains are active in every cycle, and chain-length is dictated by
a specialised C-terminal thiolesterase (TE) which releases the
fatty acid when it reaches the predesignated length.5 Similarly,
single mPKS modules have no intrinsic programmes – they
usually use all the domains available to them. Thus the fungal
HR-iPKS are uniquely programmed.
A typical example of a HR-iPKS is the squalestatin tetrake-
tide synthase (SQTKS) which catalyses the synthesis of 1 from
acetate, malonate, S-adenosyl methionine (SAM) and NADPH.6
1 forms the sidechain of squalestatin S1 2,7,8 a potent inhibitorThis journal is © The Royal Society of Chemistry 2017
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View Article Onlineof squalene synthase and potential anticholesterol compound.9
SQTKS performs three rounds of chain extension catalysed by
the AT and KS domains. Aer the rst extension the chain is
methylated (C-MeT), the b-carbonyl is reduced (KR), the chain
is dehydrated (DH), and nal enoyl reduction (ER) saturates
the chain and installs the stereochemistry at the a-methyl
position (Scheme 1A). The second round of extension and
modication is the same; but aer the third round of extension
no methylation or enoyl reduction occur and further synthesis
ceases.
In previous work we have investigated the programming of
the tenellin HR-iPKS (known as TENS) through the construction
of domain-swap chimeras with donor domains from the des-
methylbassianin synthase which makes a longer, but less
methylated polyketide.10 That work showed that some domains,
such as C-MeT, may control their own programming, possibly
via strict substrate selectivity – in other words domains may
accept or reject varying substrates presented by the ACP.
However exchange of the chain-extending KS domain, and
chain oﬀ-loading domains did not change the chain-length.
Instead, chain-length was strongly aﬀected by exchange of the
KR domain. This leads to an alternative hypothesis in which
kinetic competition between domains could control program-
ming choices.10
In order to investigate these hypotheses in more detail, and
whether similar factors aﬀect other HR iPKS domains which
have not thus-far been investigated, we set out to examine the
selectivity of isolated HR-iPKS domains in vitro. For this
purpose we selected the SQTKS ER domain which is active aer
the rst two chain extensions (i.e. diketide 3 and triketide 4 are
substrates), but inactive aer the third extension (i.e. tetraketide
1 is not a substrate, Scheme 1B).Scheme 1 Programmed biosynthesis of squalestatin tetraketide syn-
thase. (A) Iterative reactions catalysed by SQTKS; (B) deduced
substrates for the ER domain.
This journal is © The Royal Society of Chemistry 2017Results
Protein production, substrate synthesis and assay procedure
SQTKS is encoded by the phpks1 gene from Phoma species
C2932 and it has previously been heterologously expressed in
Aspergillus oryzae.6 In order to obtain suﬃcient soluble protein
for in vitro assays, however, we reconstructed phpks1 using
synthetic DNA optimised for E. coli expression by homologous
recombination in yeast. The resulting full-length phpks1 was
then used as a template for PCR using a number of possible PCR
primers around the putative ER encoding sequence (see ESI for
details†). The resulting PCR products were expressed in E. coli
as his6-tagged fusion proteins and the clone which produced
the most soluble protein selected for further study. In general
protein production and purication of the isolated domain was
complicated by low yields, instability and precipitation, but
signicant improvements to standard procedures included low
temperature induction, use of low IPTG concentrations and
inclusion of 20% glycerol in all purication and storage buﬀers.
MS analysis of the protein (MALDI and ESMS) conrmed the
expected size (38.9 kDa), and calibrated gel-ltration chroma-
tography indicated that the ER domain exists as a dimer in
solution (see ESI†).Scheme 2 Synthesis of substrate SNACs and pantetheines. (A) Struc-
tures assessed; shown as free acids and designated, e.g. 5S or 5P, for
the corresponding SNAC and pantetheine thiolesters; (B) synthetic
routes to SNACs and pantetheines.
Chem. Sci., 2017, 8, 1116–1126 | 1117
Fig. 1 Kinetic parameters obtained for in vitro assay of the indicated pantetheine substrates with the isolated ER domain. Compounds 9P and 1P
showed no measurable activity.
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View Article OnlineInitial in vitro assays consisted of the isolated ER protein,
NADPH (NADH was not turned-over), the diketide tigloyl SNAC
5S and buﬀer. The reaction was followed over a period of hours
by LCMS which clearly showed the slow conversion of the
substrate to 2-methylbutyryl SNAC 6S. The ER could also be
assayed by directly observing NADPH consumption at 340 nm.
The mPKS spinosyn (KR–ER)2 didomain has been similarly
investigated in vitro (vide infra). In the case of the spinosyn ER,
hydration of a crotonyl substrate was observed,11 but addition of
water was not observed in our assays (LCMS analysis).Substrate selectivity
Diketide and longer substrate acids (5 and 7–25) were either
commercially available or synthesised by standardmethods (see
ESI†). The acids were then coupled with SNAC (to give series S)
by standard procedures. The acyl pantetheines (series P) were
made either by coupling to the 100,120 dimethyl acetonide of
pantetheine,12 followed by deprotection (for the 2-substituted
series) or by conversion to the corresponding acyl chloride and
direct thiolesterication with pantetheine itself (for the
2-unsubstituted series, Scheme 2B). All pantetheines were
puried by mass-directed HPLC fractionation. All compounds
were fully characterised prior to assays (see ESI†).
In general SNACS are relatively poor substrates of the iso-
lated ER, and for triketide and longer SNAC substrates (e.g. 15S)
low solubility becomes a limiting factor. However, acyl pan-
tetheines are generally better substrates than the corresponding1118 | Chem. Sci., 2017, 8, 1116–1126acyl SNACS, e.g. tigloyl pantetheine 5P was reduced approxi-
mately 12 times faster by the isolated ER domain under
standardised conditions than tigloyl SNAC 5S (see ESI†). For
these reasons the pantetheine series of substrates was used to
characterise the substrate selectivity of the isolated ER domain.
KM and kcat values were measured (Fig. 1) using the continuous
spectrophotometric assay (see ESI†).
Squalestatin tetraketide 1P itself is not a substrate for the ER
in vivo or in vitro. However it does act as an inhibitor of the ER
in vitro, showing observable reduction in turnover of the
substrate 5P (see ESI†).Stereoselectivity
Previous studies of the stereoselectivity of ER proteins have
relied on classical methods, relying on the use of auxiliary
enzymes with known stereoselectivities to determine the site of
label incorporation.13 We wished to develop a new, more rapid,
and directly observed assay and extend previous work which
had shown that NMR is a convenient tool for stereochemical
assessment.14 In initial work, and in order to study the stereo-
chemistry of the 2-methylbutyrate 6 produced by the isolated
SQTKS ER domain, we used Parker's in situ NMR assay for
determination of chirality at the 2-position of carboxylic acids.15
The 1H NMR spectrum of racemic 2-methylbutyric acid ()-6
was measured rst (Fig. 2A) at 500 MHz in CDCl3. In the pres-
ence of 1R,2R-1,2-diphenylethylenediamine 26 the methyl
resonances of 6 are shied to higher eld and the R and SThis journal is © The Royal Society of Chemistry 2017
Fig. 2 Stereochemical outcome at the 2-position after reduction by
the isolated ER domain. NMR spectra show the methyl region of 6 at
500 MHz.
Scheme 3 Stereoselectivity at the cofactor. Preparation and use of
NADPD stereoisomers. ADH ¼ alcohol dehydrogenase; GDH ¼
glucose-1-dehydrogenase. R ¼ adenine dinucleotide phosphate.
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View Article Onlineenantiomers are resolved (Fig. 2B). When the same conditions
are applied to enantiopure 2S-2-methylbutyric acid a single set
of resonances is observed as expected (Fig. 2C).
In an initial control assay S-2-methylbutyryl SNAC 6S was
incubated with the ER and all other assay components for 24 h.
At the end of the reaction the SNAC was hydrolysed and the
reaction mixture was acidied to pH 3, extracted directly into
CDCl3 and two equivalents of 1R,2R-1,2-diphenyl-ethylenedi-
amine 26 was added before examination by 1H NMR. This
showed the material remained enantiopure, indicating that no
racemisation of the reaction product occurred during the assay,
hydrolysis and isolation procedures (Fig. 2D).
Next, the isolated ER was incubated with tigloyl SNAC 5S and
an excess of NADPH for 24 h. The reaction was treated as
described above and the extracted 2-methylbutyric acid 6
examined by 1H NMR. Identical conditions were applied to
angelic SNAC 8S. In both cases the 1H NMR indicated thatThis journal is © The Royal Society of Chemistry 2017racemic product was produced (Fig. 2E and F). The same results
were obtained for the corresponding pantetheine thiolesters 5P
and 8P.
Both 40-2H diastereomers of NADPH were prepared by liter-
ature procedures16 and shown to incorporate >98% 2H by MS
analysis (Scheme 3, see ESI†). The 40-S 27 and 40-R 28 labelled
cofactors were individually incubated with tigloyl-pantetheine
5P and ER for 24 h. Reactions were slow because of kinetic
isotope eﬀects and as much ER protein was used as possible to
compensate. At the end of reaction the 2-methylbutyryl pan-
tetheine 6P product was isolated and examined by MS. In the
case of 40-S 2H NADPH 27 no 2H was incorporated, but >95% 2H
incorporation was observed for the 40-R 2H diastereomer 28
(Scheme 3).
In order to examine the stereoselectivity of the reduction at
the substrate 3-position, mandelate esters were examined for
their ability to resolve the diastereotopic 3-hydrogens of 6 using
NMR spectroscopy. Unlabelled material was synthesised by
coupling 2RS-2-methylbutyric acid ()-6 with 2S-methyl-
mandelate 29 to give the methylmandelate ester 2RS-30
(Scheme 4A). The total of four X  3 protons from both dia-
stereomers were not resolved in the 1D 1H NMR spectrum
(500 MHz), but were clearly resolved by correlation spectroscopy
(COSY, Fig. 3A).
In order to assign the diastereotopic C-3 protons in the COSY
spectrum, [3-2H]-2R,3S-2-methylbutyrate 6 was synthesised and
coupled to form the corresponding 2S-mandelate ester [3-2H]-
2R,3S-30. The route started from ethyl 3R-3-hydroxybutyrate 31Chem. Sci., 2017, 8, 1116–1126 | 1119
Scheme 4 Synthesis of [3-2H]-2R,3S-2-methylbutanoic acid 6 and its
methylmandelate ester 30: (i) LDA; (ii) MeI, 69%; (iii) MsCl, pyr, 76%; (iv)
LiAlD4; (v) Jones; (vi) methylmandelic acid, EDCI, DMAP, 14% (three
steps).
Fig. 3 Stereochemical outcome of ER reduction at the 3-position. (A)
COSY NMR of 2RS-2-methylbutyric methylmandelate ester 30. (B)
Assignment of 2R-methyl and 3-anti-H from synthetic material,
expansion of 4-methyl region; (C) results from incubations with
tigloyl pantetheine 5P, expansion of 4-methyl region; (D) results from
incubations with angelic pantetheine 8P, expansion of 4-methyl
region.
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View Article Onlinewhich was treated with 2 equivalents of LDA and one equivalent
of MeI to form the 2R,3R-2-methyl-3-hydroxy butyrate 32. The
stereoselectivity of this Frater–Seebach methylation is well
established to give the anti product.17 Activation of the alcohol
as the mesylate 33 was followed by reduction with LiAlD4 to
form [1,1,3-2H3]-2R,3S-2-methylbutanol 34. The alcohol was
oxidised to [3-2H]-2R,3S-2-methylbutanoic acid 6 using Jones
reagent and the resulting acid was esteried with 2S-methyl
mandelate to give the ester 30 (Scheme 4B). Examination of the
1H NMR spectra of [3-2H]-2R,3S-30 showed that the 4-methyl
group of the 2R diastereomer resonates at 0.92 ppm (Fig. 3B).
Comparison with racemic material 30 then showed that the
4-methyl of the 2S diastereomer resonates at 0.98 ppm. The C-3
proton anti to the 5-methyl resonates at lower eld (1.75 ppm)
than the 3-syn proton (1.52 ppm, Fig. 3B, see ESI† for full details
of assignment).
The 3-deuterated pantetheine product from the ER reaction,
[3-2H]-6P, was hydrolysed and also coupled to 2S-methyl-
mandelate to form the mandelate ester [3-2H]-30. This showed
the presence of methyl doublets at 0.92 (R) and 0.98 (S) indi-
cating that the compound was racemic at the 2-position as ex-
pected (Fig. 3C). The 2R product showed exclusive coupling
between the 4-methyl resonance and a 3-syn proton, while the
2S product showed exclusive coupling between its 4-methyl
resonance and a 3-anti proton (Fig. 3C). This shows that the
3-position possesses R conguration for both 2-epimers, indi-
cating exclusive 3-Re hydride attack during the reduction.
The ER reaction was repeated using angelic pantetheine 8P
as the substrate. The same NMR analysis once again showed
(Fig. 3D) the formation of a racemic product (methyl doublets at
0.92 and 0.98 ppm). In this case, however, the 4-methyl of the 2R
diastereomer coupled to a 3-anti proton, while the 4-methyl of
the 2S diastereomer coupled to a 3-syn proton, indicating1120 | Chem. Sci., 2017, 8, 1116–1126formation of the 3S conguration for both 2-epimers from 3-Si
hydride attack. The angelic pantetheine used contained some
tigloyl pantetheine which arises from spontaneous and
unavoidable isomerisation. The COSY NMR showed the
formation of products corresponding to reaction of tigloyl
pantetheine and integration of the COSY peaks showed this to
account for 32% of the product (see ESI†).This journal is © The Royal Society of Chemistry 2017
Fig. 4 (A) View of the overall structure of the SQTKS ER domain with NADPH and the triketide substrate 15P docked in the active site; (B) view of
the active site of SQTKS ER model with 15P docked. Left, view from substrate binding domain; right, view from cofactor binding domain; (C)
tetraketides docked in the ER active site, left, octenoyl pantetheine 19P; right, squalestatin tetraketide pantetheine 1P. Both viewed from
substrate binding domain. Colours: red, cofactor binding domain; blue, substrate binding domain; green, Rossmann fold; grey, C-terminal
sequence; yellow, NADPH, magenta docked pantetheine substrate.
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View Article OnlineModel structure
Extensive eﬀorts were made to obtain structural information on
the ER domain. Protein crystals could be obtained, but these
were not suitable for structural solution. As an alternative,
a model was built using the Swiss-Model homology modeling
server18 with the crystal structure of vertebrate fatty acid syn-
thase (2vz9)19 serving as the template.
The model consists of three main structural features
(Fig. 4A). The N-terminus (G1886–I2001, blue in Fig. 4) formsThis journal is © The Royal Society of Chemistry 2017a globular domain which appears to be involved in contacting
the acyl-pantetheine substrate. The central sequence V2002–
V2144 (red/green in Fig. 4) forms a globular cofactor-binding
domain and includes a canonical Rossmann fold (green in
Fig. 4). Finally the C-terminal sequence (grey in Fig. 4) forms
a link between the cofactor and substrate binding domains as
well as part of a capping region above the active site. The model
shows that the active site of the ER consists of an extended
tunnel between the cofactor and substrate-binding domains,
into which the NADPH cofactor extends, with the nicotinamideChem. Sci., 2017, 8, 1116–1126 | 1121
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View Article Onlinelocated deep (16 A˚) inside the protein. The NADPH contacts one
side of the tunnel made up from the N-terminal domain of the
ER, making specic contacts with residues S2072 and K2055
(nucleotide 20 phosphate), G2029 (diphosphate), I2119 and
V2144 (nicotinamide amide). All these residues are conserved in
other PKS and vFAS ER domains (see ESI†). Of the two nico-
tinamide 40 hydrogens, the pro-S hydrogen faces the surface of
the NADPH-binding domain and is unavailable for reaction.
However, the nicotinamide 40-pro-R hydrogen is exposed in
agreement with the in vitro assay data which shows that this is
transferred as hydride to the substrate. The active site tunnel
broadens around the nicotinamide and extends past it, making
an extended chamber formed by residues from the cofactor- and
substrate-binding domains and the C-terminal sequence.
Pantetheine substrates were docked into the active site by
manually placing them in approximate positions using PyMol.20
These initial poses were then minimised using the YASARA
algorithm.21 In the case of the triketide pantetheine 15P this
docking procedure resulted in a model in which the pan-
tetheine extends parallel to the adenine diphosphate, locating
the thiolester and the b-carbon adjacent to the nicotinamide.
The ab-unsaturated carbonyl of the substrate adopts an s-cis
conformation which places the reactive b-carbon 3.6 A˚ away
from the cofactor's reactive 40-pro-R hydrogen (Fig. 4B). The
geminal dimethyl group of the pantetheine makes contacts with
a hydrophobic surface created by C2097 and L2098 at the
entrance to the pocket. The pantetheine chain then extends past
a largely hydrophobic surface created by N1922, F1923 and
I2001 towards a pocket which contains the substrate (vide infra).
The terminal hydroxyl of the pantetheine is located at the
entrance to the substrate tunnel suggesting that in the func-
tional PKS the substrate and pantetheine adopt an extended
conformation with the ACP in contact with the outer surface of
the ER active site, allowing delivery of the ab-unsaturated
thiolester to the nicotinamide. The model suggests the forma-
tion of two hydrogen bonds between pantetheine and NADPH:
the pantoate 2-hydroxyl hydrogen lies 2.5 A˚ from the adenine
ribose furan oxygen; and the pantothenic acid NH lies 2.4 A˚
from nicotinamide ribonucleotide 30 oxygen.
The stereochemical assays of the in vitro ER showed that it
transfers hydride from NADPH to the Re face at C-3 of tigloyl
pantetheine 5P, and the model is consistent with this geometric
constraint. Aer transfer of hydride a transient enol(ate) must
be reprotonated at the 2-carbon. In the native protein this must
happen stereoselectively on the Re-face of C-2 to provide the
observed 2-S-stereochemistry. However the model does not
show a likely proton source (e.g. tyrosine hydroxyl etc.) within
5 A˚ of the substrate 2-carbon.
Tetraketide pantetheine-bound substrates (such as 19P and
1P) were also docked using the same procedure. In the case of
the non-methylated tetraketide 19P the pantetheine, thiol and
acyl groups were located in approximately the same positions as
the triketide pantetheine 15P, forming the same hydrogen
bonds to NADPH itself, but the extended tail of the polyketide
stretches more deeply into the core of the ER into a hydrophobic
pocket formed by residues from the substrate binding domain
and the C-terminal sequence (F1941, L1969, I2001, V2004,1122 | Chem. Sci., 2017, 8, 1116–1126I2008, D2145, L2146, I2147, I2149 and F2157). The YASARA
algorithmminimises both protein and substrate conformations
and our results suggest that the active site of the ER can expand
in this region to accommodate the longer substrates. However,
for the longer compounds the ab unsaturated moiety does not
form the same s-cis conformation as the fast substrate 15P. Here
the conformation is s-trans in the case of 19P, or twisted out of
conjugation for the dimethylated tetraketide 1P. The dimethy-
lated tetraketide is also pushed further towards the top of the
active site pocket, and conformational changes occur in the
pantetheine moiety. Thus the model suggests that additional
bulk towards the tail of the polyketide, particularly branching,
may prevent the substrate from reaching a productive confor-
mation for rapid reduction.
Discussion
In vitro studies of fungal HR-iPKS are beginning to elucidate
their selectivities. For example Vederas and coworkers have
recently described investigations of the selectivity of C-MeT and
KR domains of the intact lovastatin nonaketide synthase
(LNKS).22 LNKS has an inactive cis-ER domain, but biosynthesis
of the lovastatin nonaketide requires the activity of a trans-
acting ER known as LovC which is structurally diﬀerent from cis
ERs.23 Our work shows that the active cis-ER domain of SQTKS
can be reconstituted in vitro as a stand-alone catalytic domain.
The fungal HR-iPKS show end-to-end homology with vFAS,10 for
which a crystal structure has been obtained.19 vFAS dimerizes
via signicant contacts between the ER and DH domains from
the two separate monomers. It was therefore unsurprising to
nd that the isolated SQTKS ER exists as a dimer in solution.
Although we were unable to obtain a crystal structure of the
isolated SQTKS ER domain, a model built computationally was
consistent with numerous experimental observations. For
example the structural domain organisation is consistent with
that observed for other PKS and FAS ER proteins and docking of
NADPH showed interactions with known cofactor binding
residues and the correct 40-hydrogen exposed for reaction.
Likewise, docking of substrate pantetheines gave structures
consistent with the observed stereochemistry of reduction at the
substrate 3-carbon.
The ER was shown to be catalytically active, reducing the
SNAC diketide 5S in the presence of NADPH, but enoyl SNACs
were generally poor substrates, and not amenable to the
collection of meaningful kinetic data. Much faster reaction was
demonstrated for the corresponding acyl pantetheine 5P, and
all the acyl pantetheine substrates were turned over more
quickly than their SNAC homologues. Kinetic analysis of a range
of diﬀerent acyl pantetheine substrates showed that the ER is,
in fact, tolerant of a wide range of diﬀerent substrates,
including compounds likely to be true intermediates such as 5
and 15, but also compounds: with unnatural methylation
patterns (e.g. 12, 13 and 18); unsubstituted at C-2 (e.g. 11, 17, 18,
19, 21 and 24); with odd-carbon main chains (17 and 18); with
longer main chains (e.g. 24 and 25); and even Z-alkenes (8) and
2-ethyl substrates (e.g. 10 and 16). Only the tetrasubstituted
olen 9 showed no turnover among the di-and triketides tested.This journal is © The Royal Society of Chemistry 2017
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View Article OnlineTriketides are generally better substrates (higher kcat/KM values)
than diketides or tetraketides, and in fact the unnatural mon-
omethylated triketide 12 is the best substrate tested by
a signicant factor. The 4S,6S-dimethyltetraketide 1 was not
turned over at all, and compounds with similar structures such
as 21 were also very poor substrates. Interestingly a dimethy-
lated tetraketide substrate 22 which is racemic at the 4- and
6-positions showed some detectable substrate activity, indi-
cating that the ER can slowly reduce stereoisomers of 1, but not
1 itself. Linear pentaketides are also substrates and this
suggests that the ER is uniquely sensitive to the 4S,6S-dime-
thyltetraketide 1. Inhibition studies showed that the 4S,6S-
dimethyltetraketide 1P acts as an inhibitor of the ER, so it can
clearly enter the active site of the enzyme like its close structural
analogues, but it cannot be reduced. It thus appears that the
SQTKS ER acts as a rather general catalyst, able to accommodate
and reduce many enoyl species which are passed to it, but it
exerts its ‘programming’ eﬀect by its inability to reduce the nal
tetraketide substrate.
Our results show that pantetheine substrates are processed
more eﬀectively than simple SNACs. The model reveals that
specic interactions between pantetheine and the enzyme and
cofactor are present which favour pantetheine binding over
SNAC. The model also explains how compounds such as Z, and
2-ethyl alkenes can t into the active site as the substrate-
binding pocket broadens beyond the reaction chamber. The
substrate binding pocket eventually narrows, making the
accommodation of methylated substrates more diﬃcult.
However non-methylated linear pentaketides are substrates.
We also investigated the stereoselectivity of the isolated ER
through the development of a new NMR-based assay. In intact
SQTKS the ER domain sets the stereochemistry of the two
methylated positions, presumably via a stereoselective repro-
tonation at the 2-position of an enol(ate) intermediate 35, itself
created by transfer of hydride to the 3-carbon of the enoyl
substrate (Scheme 5). Surprisingly the results of two diﬀerent
assays showed that the isolated ER cannot control the stereo-
selectivity of reprotonation at the 2-carbon. In all assays, with
both SNAC and pantetheine substrates, the product was always
racemic at the 2-carbon, and control reactions showed that this
was not caused by post-reduction racemisation or by the
extraction and analysis procedures. We reasoned that this could
be explained in two ways: either the substrate is unable to locate
in the active site in a single conformation allowing uncontrolled
addition of hydride and reprotonation; or the substrate does
locate in a single conformation allowing stereoselective addi-
tion of hydride but the reprotonation step is uncontrolled.
Highly stereoselective transfer of the 40-pro-R hydrogen of
NADPH was demonstrated, indicating that the cofactor must be
rigidly located in the active site. Furthermore we showed that
transfer of hydride to the 3-carbon of the diketide substrate is
also highly stereoselective, indicating that the substrate must
take a single conformation relative to NADPH. Surprisingly the
ER is also able to reduce Z-congured alkenes. For the diketide
angelic pantetheine 8P the stereochemical assay again showed
that hydride transfer to the 3-carbon is highly stereoselective.
Analysis of the sense of hydride addition shows that theThis journal is © The Royal Society of Chemistry 2017Z-alkene must bind in the active site in the same orientation as
the E-alkene (Scheme 5).
Thus we can rule out a situation in which the substrate binds
in alternative conformations in the active site. This leads to the
conclusion that, for the isolated ER, reprotonation at the 2-
carbon has become unselective. A model of the SQTKS ER with
the cofactor and substrate docked is fully consistent with the
experimental results. The model shows that NADPH binds into
the active site in a conformation which presents its 40-pro-R
hydrogen towards the substrate such that reduction would
occur at the Re face of the tigloyl pantetheine 5P 3-carbon.
The stereochemistry of the ER reaction of FAS systems has
been determined previously, and for diﬀerent FAS systems all
four possible modes of reduction have been observed. For vFAS
the 40-pro-R hydrogen of NADPH24 is transferred by Re addition
at the substrate 3-carbon,25 and both features match our
observation for SQTKS ER, reinforcing the similarity between
the vFAS and HR-iPKS systems. vFAS then reprotonates stereo-
selectively at the Si face of the 2-position26 so that overall
delivery of hydrogen occurs syn (Scheme 5). For native SQTKS
the reprotonation at the 2-position must be opposite, giving the
observed anti addition of hydrogen, presumably arising by
alternative positioning of the proton donor. Vederas also
showed that fungal FAS (fFAS) and the PKS responsible for
cladosporin biosynthesis in Cladosporium cladosporioides have
opposite protonation selectivities at the 2-position using in vivo
isotopic labelling assays: fFAS reprotonates on the Si face; while
the PKS reprotonates on the Re face.27 Fungal PKS domains have
thus diverged from their FAS counterparts in this respect.
However, it appears that the stereochemistry of 2-reprotonation
is easily disturbed in the SQTKS ER, raising questions regarding
the identity of the proton donor.
Examination of the ER model does not show a likely protein
residue which could be responsible for reprotonation of the
enol(ate) intermediate within 5 A˚ of the substrate 2-carbon. Ban
and coworkers suggested that K1771 and/or D1797 of vFAS
could be the residues responsible for the reprotonation step. In
the SQTKS ER, K1771 is conserved (see ESI†), but the amino
group is 9.7 A˚ distant from the reacting 2-carbon. D1797 is not
conserved in the SQTKS sequence, although an aspartate is
present as D1795 (vFAS numbering): the closest oxygen is 6.5 A˚
distant from the 2-carbon, and almost coplanar with the C1–C2
enol(ate) of the substrate and it may therefore be unable to
protonate the 2-carbon.
Leadlay and coworkers have studied the reprotonation
question in erythromycin (ery) ER4 and rapamycin (rap) ER13
domains.28 There was strong sequence-based evidence for
residue 1584 (vFAS numbering) being involved in stereo-
selectivity at the 2-position. When this residue is Y in some
modular PKS ER domains then 2S-congured products are
formed (Si protonation), otherwise 2R-congured products are
produced (Re protonation). This suggested that Y1584 might be
responsible for protonation. However, vFAS ER has L instead of
Y at this position, and it protonates the enolate Si. The SQTKS
ER also has L at this position and it reprotonates Re in the WT
PKS. Thus the picture is unclear. Furthermore, mutation
V1584Y in rap ER13 did not cleanly change the selectivity from RChem. Sci., 2017, 8, 1116–1126 | 1123
Scheme 5 Stereochemical course of the reduction catalysed by the SQTKS isolated ER domain and its comparison with ER reduction by vFAS.
Chemical Science Edge Article
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
6 
Se
pt
em
be
r 2
01
6.
 D
ow
nl
oa
de
d 
on
 5
/3
0/
20
19
 1
1:
15
:4
6 
A
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Onlineto S. Other possible residues including N1573, D1576 and Y1657
as well as K1771 (vFAS numbering) were also proposed.29
However mutagenesis did not strongly support the role of any of
these residues in controlling the stereoselectivity of the
protonation step.
In the SQTKS ER these residues are also conserved, and the
model shows that while N1573 is only 5.7 A˚ from the reacting
2-carbon, D1576, L1584 and Y1657 are further away (7.9, 8.8 and
11.7 A˚ respectively, vFAS numbering). However N1573 and
D1576 are correctly placed to give protonation at the required Re
face, while if position 1584 were Y it could protonate the Si face.
Thus neither our model, or the suggestions of previous workers
can adequately explain the source of the stereoselective repro-
tonation. Thus it may be that the proton is supplied by a judi-
ciously placed water molecule, itself held in place by diverse
residues. In the isolated SQTKS ER domain it is clear that the
reprotonation has become unselective and we propose that
removal of the other surrounding catalytic domains induces
additional exibility into the ER active site allowing ingress of
excess water to both faces of the intermediate enol(ate) 35,1124 | Chem. Sci., 2017, 8, 1116–1126although further experiments will be required to verify this
hypothesis.Conclusions
Overall our results show that the SQTKS ER is a broadly
substrate-tolerant domain, with low intrinsic selectivity for
diketides and triketides. It does not strictly reject tetraketides,
allowing them into its active site and appearing to control the
reduction by subtle conformational eﬀects probably induced by
the methylation pattern distil from the reactive carbons. The
results diﬀer from those of Vederas and coworkers22 who
showed that the C-MeT domain of LNKS shows high substrate
selectivity, but more closely match the conclusions for the LNKS
KR domain which shows a lower level of selectivity.
These results reinforce a growing body of evidence which
supports a programming mechanism for HR iPKS based upon
kinetic competition by catalytic domains for individual
substrates. In other words the programme decision at any
point is not made by a single catalytic domain, but by theThis journal is © The Royal Society of Chemistry 2017
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View Article Onlinerelative rates of two (or more) competing domains. Any given
ACP-bound intermediate can be a substrate for two or more of
the PKS catalytic domains. For example triketide olen 15
could be a substrate for the ER or could be passed back to the
KS for chain-extension by the AT. In this case the ER must react
faster than the AT, producing a fully saturated product which
can then only be a substrate for further chain extension. At the
tetraketide stage 1 cannot be reduced by the ER and chain-
release (by an as-yet undetermined mechanism) must be faster
than AT/KS. Our results also suggest a role for sequestration of
substrates by domains which are not catalytically active, for
example 1 can enter the ER even though it is not reduced, and
this may prevent the AT passing the substrate to the KS for
further extension. The time substrates spend in non-reacting
domains may also inuence competition and thus program-
ming. Current kinetic assays cannot yet probe these non-cata-
lytic interactions.
This model of competition for substrates by diﬀerent
enzymes also oﬀers an explanation for the observation that
HR iPKS such as TENS and LNKS display reduced program-
ming delity in diﬀerent circumstances – the fact that
domains such as ER and KR can posses broad substrate
selectivity allows them to respond to unusual substrates
without jamming the entire PKS. Such a mechanism could
also allow the rapid evolution of new polyketides by a PKS
through the accumulation of subtle selectivity changes in
individual domains. The results oﬀer possibilities for future
engineering of HR iPKS systems – for example expansion of
the active site of SQTKS ER may allow longer chains to be
synthesised. Our work in this area currently focuses on
obtaining more kinetic evidence for other isolated HR iPKS
domains and the development of new methods for studying
domain selectivity and competition.Acknowledgements
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